4-(3-(4-CYANO-3-(TRIFLUOROMETHYL)PHENYL)-5,5-DIMETHYL-4-OXO-2-THIOXOIMIDAZOLIDIN-1-YL)-2-FLUOROBENZOIC ACID, 95%, 250mg

DL-Alanyl-DL-leucine>95.0%(HPLC)(T)100mg

(4-(Difluoromethyl)-2-oxabicyclo[2.1.1]hexan-1-yl)methanol, 98%, 500mg

2-(tert-Butoxy)pyridine, 95.0%, 25g

ETHYL 3-(2-(((4-(N-((HEXAN-2-YLOXY)CARBONYL)CARBAMIMIDOYL)PHENYL)AMINO)METHYL)-1-METHYL-N-(PYRIDIN-2-YL)-1H-BENZO[D]IMIDAZOLE-5-CARBOXAMIDO)PROPANOATE, 95%, 50mg

Indium foil 99.999% 0.1 x 100 x 100 mm 1 pc

4-Fluoro-5-methoxy-2-methyl-1H-indole, 95.0%, 5g

2-(Pyridin-2-yl)-4H-benzo[e][1,3]thiazin-4-one, 97.0%, 250mg

(R)-TERT-BUTYL 2-(2-(METHYLAMINO)THIAZOL-4-YL)PYRROLIDINE-1-CARBOXYLATE, 90.0%, 2g

Dabigatran>95.0%(HPLC)100mg

4-Chloro-1,1-dimethyl-1H,3H-furo[3,4-c]pyridin-3-one, 97%, 100mg

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzene-1,2-diamine, 97%, 25g

tert-Butyl 3-bromopicolinate, 97.0%, 5g